Log in to save to my catalogue

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national Europea...

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national Europea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_aa3f45fd445f4117b36899935a16679d

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We hypothesized that machine learning (ML) models could be used to predict risks at different stages of management and thereby provide insights into drivers and prognostic markers of disease progression and death. From a cohort of approx. 2.6 million citizens in Denmark, S...

Alternative Titles

Full title

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_aa3f45fd445f4117b36899935a16679d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_aa3f45fd445f4117b36899935a16679d

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-81844-x

How to access this item